Parallax Volatility Advisers’s Integra LifeSciences IART Stock Holding History

Parallax Volatility Advisers’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,157	Closed	-$291K	–	3009
2020 Q3	$291K	Buy	+6,157	New	+$293K	﹤0.01%	2415
2018 Q4	–	Sell	-51	Closed	-$3K	–	3348
2018 Q3	$3K	Sell	51 -3	-6%	-$186	﹤0.01%	2374
2018 Q2	$3K	Buy	54 +3	+6%	+$186	﹤0.01%	1881
2018 Q1	$3K	Sell	51 -9,609	-99%	-$504K	﹤0.01%	1986
2017 Q4	$462K	Buy	+9,660	New	+$473K	﹤0.01%	1587

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallax Volatility Advisers's IART Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Integra LifeSciences (IART) in Q4 2020, closing a stake of 6,157 shares — an estimated $291K sold.

Parallax Volatility Advisers first reported a position in IART in Q4 2017 and held it in 5 quarters. The position peaked at $462K in Q4 2017. 251 funds tracked by Wall St. Rank hold IART as of Q4 2020.

Parallax Volatility Advisers reported no remaining Integra LifeSciences position as of Q4 2020 after selling out during the quarter.
Parallax Volatility Advisers sold 6,157 Integra LifeSciences shares in Q4 2020, an estimated $291K.
Parallax Volatility Advisers first reported a position in Integra LifeSciences in Q4 2017 and held it in 5 quarters.
Parallax Volatility Advisers's Integra LifeSciences position peaked at $462K in Q4 2017.
251 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.